CD274 and cancer: These synthetic circRNAs can act as decoys for immune checkpoint proteins, such as PD-L1, thereby enhancing the body’s immune response against tumors.174 Collectively, these therapeutic strategies underscore the versatile potential of circRNAs in cancer treatment, offering novel avenues to target and overcome the molecular complexities of cancer.